Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
ExecutiveGov

Northrop’s Talon Prototype Gets Air Force MDS Designation

The U.S. Air Force has designated Northrop Grumman’s semi-autonomous prototype aircraft, Project Talon, as YFQ-48A as part of ...
The National Interest on MSN

Northrop Grumman’s YFQ-48A drone is contending for the Air Force’s CCA program

The YFQ-48A drone is now the third drone vying for the US Air Force’s “Collaborative Combat Aircraft” program, following General Atomics’ YFQ-42A and Anduril’s YFQ-44A.
The Aviationist

Northrop Grumman’s Project Talon CCA Designated YFQ-48A by U.S. Air Force

The U.S. Air Force says the YFQ-48A Mission Design Series acknowledges Northrop Grumman’s Project Talon as a “strong contender” for the CCA program. The ...